Herpes zoster
Senast uppdaterad: Senast reviderad:
Sakkunnig:Mikael Tarstedt
Definition:
Reaktivering av varicella zoster-virus, kallas även bältros.
Förekomst:
Incidensen är cirka 2 per 1 000 invånare per år.
Symtom:
Symtomen börjar oftast med avgränsade, brännande smärtor. Efter några dagar får patienten vanligtvis vesikulärt utslag, eventuellt feber.
Kliniska fynd:
Ensidigt vesikulärt utslag inom ett dermatom.
Diagnostik:
Typisk klinisk bild. Kompletterande undersökningar är ofta inte nödvändiga.
Behandling:
Smärtbehandling i den akuta fasen. Systemisk antiviral behandling till personer med komplicerad zosterinfektion, immunsupprimerade och till personer >50 år. Antiviral behandling bör påbörjas medan det fortfarande finns färska lesioner, vanligtvis inom 2–3 dygn efter ett utbrott.
- Saguil A, Kane S, Mercado M, Lauters R. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician. 2017;96(10):656-663. PMID: 29431387 PubMed
- Mounsey AL, Matthew LG, Slawson DC. Herpes zoster and postherpetic neuralgia: Prevention and management. Am Fam Physician 2005; 72: 1075-80. PubMed
- Vaccination mot bältros – vägledning för hälso och sjukvårdspersonal. Folkhälsomyndigheten. Hämtad 2021-10-27. www.folkhalsomyndigheten.se
- Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341. PubMed
- Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20: 748-53. PubMed
- Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347: 340-6. PubMed
- Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84. PMID: 15930418 PubMed
- Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for herpes zoster: population based case-control study. BMJ 2014; 348: g2911. BMJ (DOI)
- Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of post-herpetic neuralgia after a first episode of herpes zoster: a prospective study with long term follow up. BMJ 2000; 321: 794-6. PMID: 11009518. PubMed
- Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 Suppl 1: S1.
- Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191: 2002. PubMed
- Albrecht MA. Clinical manifestations of varicella-zoster virus infection: Herpes zoster. UpToDate, last updated July 6, 2009. UpToDate
- Bältros. Nationellt kliniskt kunskapsstöd (NKK) (hämtad 230718) www.nationelltklinisktkunskapsstod.se
- Werner RN, Nikkels AF, Marinović B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):20-29. PMID: 27579792. PubMed
- Albrecht MA. Treatment of herpes zoster in the immunocompetent host. UpToDate, last updated Jul 21, 2016. www.uptodate.com
- Berry JD, Petersen KL. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005; 65: 444-7. PMID: 16087911 PubMed
- Varicella, herpes zoster and nonsteroidal anti-inflammatory drugs: serious cutaneous complications. Prescrire Int. 2010;19(106):72-73. PMID: 20568491 PubMed
- Inaba I, Kondo Y, Iwasaki S, et al. Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions. Front Pharmacol. 2019;10:874. PMID: 31440161 PubMed
- Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD005582. DOI: 10.1002/14651858.CD005582.pub4. DOI
- Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866. PMID: 24500927 PubMed
- Johnson BH, Palmer L, Gatwood J, et al. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis. 2015;15:502. PubMed
- Wood MJ, Shukla S, FIddian AP, Crooks RJ. Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain. J Infect Dis 1998; 178 (Suppl 1): S81-S84.
- McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther 2011; : doi: 10.3851/IMP2011. DOI
- Pasternak B, Hviid A. Use of acyclovir, valacyklovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304: 859-66. PMID: 20736469. PubMed
- Wiffen PJ, Derry S, Moore RA, et al.Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013 Nov 11;11:CD010567. doi: 10.1002/14651858.CD010567.pub2. DOI
- Vaccin mot bältros (herpes zoster). Folkhälsomyndigheten. Hämtad 2020-10-29 www.folkhalsomyndigheten.se
- Harbecke R, Cohen JI, Oxman MN. Herpes Zoster Vaccines. J Infect Dis. 2021 Sep 30;224(Supplement_4):S429-S442. doi: 10.1093/infdis/jiab387. PMID: 34590136; PMCID: PMC8482024
- Gagliardi AM, Andriolo BN, Torloni MR, et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2019 Nov 7;2019(11). doi: 10.1002/14651858.CD008858.pub4. DOI
- Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37. PMID: 20565946 PubMed
- Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005 Jun;6(6):356-63. doi: 10.1016/j.jpain.2005.01.359. PMID: 15943957 PubMed
- Breuer J, Pacoud M, Gauthier A, Brown MM. Herps zoster as a risk factor for stroke and TIA. Neurology 2014. PMID: 24384645.
- Thyregod HG, Rowbotham MC, Peters M, Possehn J, Berro M, Petersen KL. Natural history of pain following herpes zoster. Pain 2007; 128: 148-156. PMID: 17070998 PubMed
- Mikael Tarstedt, Överläkare, Hudmottagningen, Karlskoga lasarett
- Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet